In India’s fast-changing wellness landscape, mental health is no longer a quiet conversation’s a movement. Over the past few years, a new generation of startups has redefined how therapy, emotional well-being, and digital care reach millions. From AI-driven mental health companions to holistic therapy platforms, India’s FY24 trailblazers are proving that innovation can heal, too….
Read moreCategory: Reports
Posts that explain reports that we release periodically around unlisted markets. All reports are downloadable freely from privatecircle.co.
Inito Health Tech: Reinventing Fertility Care with Data
Company Overview & Business Model Founded in April 2024, Inito Health Tech Private Limited, operating under the brand Inito, is decisively positioned at the forefront of at-home diagnostics for women’s fertility and hormonal health. From the very beginning, the company has focused on one clear mission: bringing lab-grade fertility insights directly into consumers’ hands. At…
Read moreD2C Streetwear Brands Redefining Swag in IndiaÂ
India’s streetwear revolution has moved far beyond niche fashion circles. What began as a subculture inspired by hip-hop, sneaker communities, and indie creators has now become a mainstream movement. Today’s youth want drops instead of traditional collections, identity-led designs instead of generic fashion, and brands that speak their culture, not just sell clothing. This shift…
Read moreWhat Became Fabindia’s Star Product in FY25?
Introduction: A Legacy Brand Reinventing Itself Fabindia is one of India’s most iconic lifestyle and ethnic-wear brands, a company that has built its identity on handcrafted textiles, rural craftsmanship, and contemporary Indian aesthetics. Founded in 1960, the brand has grown from a small exporter of handwoven fabrics to a diversified retail powerhouse spanning garments, home…
Read morePre-IPO Precision: How Steadview Timed India’s Biggest Listings
In India’s fast-evolving public markets, few investors have mastered the art of timing like Steadview Capital. Known for backing category leaders just before their big market debuts, Steadview’s pre-IPO strategy reveals a powerful mix of patience, precision, and conviction. Between 2020 and 2025, Steadview placed key bets across emerging tech, fintech, logistics, and retail. From…
Read moreFang Oral Care: The D2C Brand Set for Hypergrowth
Couch Commerce operates under the brand Fang Oral Care, delivering premium, toxin-free dental hygiene solutions, including: With a product portfolio rooted in clinical research, sustainability, and consumer-centric design, the company has, year after year, demonstrated extraordinary resilience and exceptional momentum. Founded in 2015, the company has crossed over 10 years of operations, and as of…
Read moreHow Indian Men’s Grooming Brands Are Shaping Global Style
Introduction The Indian men’s grooming industry has transformed from a niche segment into a global phenomenon. What started with beard oils and razors has now evolved into a holistic wellness movement that spans skincare, haircare, nutrition, and lifestyle products.A new generation of Indian brands is redefining masculinity, combining technology, design, and indigenous innovation to create…
Read moreTPG’s Investment Journey: From Early Investment to IPO Returns
If you study India’s biggest value-creation stories over the past decade, one trend becomes clear:The real money was made before the IPO bell rang. Among global private equity firms operating in India, TPG Capital stands out for its ability to identify scalable businesses early, invest with discipline, and exit with conviction at the moment of…
Read moreNephroPlus IPO: Who’s Monetising Their Stake in the OFS?
A Deep Dive Into Value Unlock, Investor Journeys & Market Timing The NephroPlus IPO has arrived with remarkable buzz. And understandably so. After all, this isn’t merely another healthcare listing; rather, it’s the culmination of a decade-long journey powered by patient capital, strategic partnerships, and consistent scale-up. Moreover, the Offer for Sale (OFS) attached to…
Read moreWho Made the Most? Investor – Wise Payoffs from the Corona Remedies IPO
Corona Remedies Limited is an Indian pharmaceutical company, incorporated in 2004, that develops, manufactures and markets branded pharmaceutical formulations across multiple therapeutic areas, including women’s healthcare, cardio-diabeto (cardio-metabolic), pain management, urology, and more. Over the years, Corona Remedies has carved out a niche for itself in India’s domestic pharmaceutical market. By June 2025, the company…
Read more





